Contribute to CUGH's Travel Bursary for Colleagues from LMICs To Present at CUGH2019

Dear Colleague,

It is often prohibitive for faculty and students from low & low-middle income countries (LLMIC) to attend our annual conference. To help address this problem, CUGH has a LLMIC travel bursary program. We provide travel support for select faculty and students from LLMICs who have been invited to present at CUGH2019. Please support our colleagues and donate to our bursary program. Please see the attached flyer and kindly share it with your network.

CUGH is a 501(c)(3) non-profit organization. All donations are tax deductible in the US.

Webinar: Global Health Competencies Toolkit | 2nd Edition: Launch & Updates

Global Health Competencies are central to Global Health education at undergraduate and graduate levels. The CUGH Competencies Toolkit is an essential resource for educators - including over 1000 multimedia teaching objects to use inside and outside the classroom, assisting faculty to nurture Global Health knowledge, skills and attitudes.

Join this webinar to learn more about how CUGH can assist faculty in all disciplines approaching Global Health to further the perspectives of learners and fellow faculty.

Thursday, October 18, 2018 - 1:00pm to 2:00pm
Associated Committee(s): 

Get Out & Vote on Nov. 6

One of the most important things you can do as a US citizen is to register and vote. On November 6, 2018 vote for candidates who support addressing the global health challenges we face, both international and domestic. See how to register and vote here. Remind your family and friends to do so, too. See how you can vote here and share our 'Get Out And Vote' flyer below.

Featured Video: Two Countries, Two Choices: India, South Africa and the Struggle against MDR-TB

A new documentary film by AIDS-Free World: The drugs Bedaquiline and Delamanid can mean the difference between life and death for people suffering from the worst and most noxious strain of tuberculosis in the world, MDR-TB. The government of India has restricted access to the drugs for its 140,000 MDR-TB sufferers. South Africa has made a different choice for 20,000 MDR-TB patients. The consequences are profound.

Pages